Thomas J. Schaefer - Jan 3, 2023 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Financial Officer
Signature
Thomas Schaefer, by Attorney-in-fact, Solaeta Chan
Stock symbol
RKDA
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 08:07 PM
Next filing
Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (Right to Buy) Award $0 +50K +45.87% $0.00 159K Jan 3, 2023 Common Stock 50K $0.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 1/3/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.